BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23186176)

  • 1. Sphingosine and the transient receptor potential channel kinase(s).
    Rohacs T
    Br J Pharmacol; 2013 Mar; 168(6):1291-3. PubMed ID: 23186176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels.
    Qin X; Yue Z; Sun B; Yang W; Xie J; Ni E; Feng Y; Mahmood R; Zhang Y; Yue L
    Br J Pharmacol; 2013 Mar; 168(6):1294-312. PubMed ID: 23145923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7.
    Chubanov V; Mederos y Schnitzler M; Meißner M; Schäfer S; Abstiens K; Hofmann T; Gudermann T
    Br J Pharmacol; 2012 Jun; 166(4):1357-76. PubMed ID: 22242975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing TRPM7 promotes growth/proliferation and nitric oxide production of vascular endothelial cells via the ERK pathway.
    Inoue K; Xiong ZG
    Cardiovasc Res; 2009 Aug; 83(3):547-57. PubMed ID: 19454490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPM7 regulates proliferation and polarisation of macrophages.
    Schilling T; Miralles F; Eder C
    J Cell Sci; 2014 Nov; 127(Pt 21):4561-6. PubMed ID: 25205764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine and FTY720 modulate pacemaking activity in interstitial cells of Cajal from mouse small intestine.
    Nam JH; Kim WK; Kim BJ
    Mol Cells; 2013 Sep; 36(3):235-44. PubMed ID: 23912597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TRPM6 kinase domain determines the Mg·ATP sensitivity of TRPM7/M6 heteromeric ion channels.
    Zhang Z; Yu H; Huang J; Faouzi M; Schmitz C; Penner R; Fleig A
    J Biol Chem; 2014 Feb; 289(8):5217-27. PubMed ID: 24385424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waixenicin A inhibits cell proliferation through magnesium-dependent block of transient receptor potential melastatin 7 (TRPM7) channels.
    Zierler S; Yao G; Zhang Z; Kuo WC; Pörzgen P; Penner R; Horgen FD; Fleig A
    J Biol Chem; 2011 Nov; 286(45):39328-35. PubMed ID: 21926172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of TG100-115 as a new and potent TRPM7 kinase inhibitor, which suppresses breast cancer cell migration and invasion.
    Song C; Bae Y; Jun J; Lee H; Kim ND; Lee KB; Hur W; Park JY; Sim T
    Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):947-957. PubMed ID: 28161478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of TRPM6 and TRPM7 Proteins in Normal and Diseased Cardiac Atrial Tissue and Isolated Cardiomyocytes.
    Andriulė I; Pangonytė D; Gwanyanya A; Karčiauskas D; Mubagwa K; Mačianskienė R
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCT128930 is a novel and potent antagonist of TRPM7 channel.
    Guan Z; Chen X; Fang S; Ji Y; Gao Z; Zheng Y
    Biochem Biophys Res Commun; 2021 Jun; 560():132-138. PubMed ID: 33989904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the melastatin-related cation channel TRPM3 by D-erythro-sphingosine [corrected].
    Grimm C; Kraft R; Schultz G; Harteneck C
    Mol Pharmacol; 2005 Mar; 67(3):798-805. PubMed ID: 15550678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium-inhibited, TRPM6/7-like channel in cardiac myocytes: permeation of divalent cations and pH-mediated regulation.
    Gwanyanya A; Amuzescu B; Zakharov SI; Macianskiene R; Sipido KR; Bolotina VM; Vereecke J; Mubagwa K
    J Physiol; 2004 Sep; 559(Pt 3):761-76. PubMed ID: 15272039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological agents selectively acting on the channel moieties of TRPM6 and TRPM7.
    Rössig A; Hill K; Nörenberg W; Weidenbach S; Zierler S; Schaefer M; Gudermann T; Chubanov V
    Cell Calcium; 2022 Sep; 106():102640. PubMed ID: 36030694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TRPM7 Channel in the Nervous and Cardiovascular Systems.
    Inoue K; Xiong ZG; Ueki T
    Curr Protein Pept Sci; 2020; 21(10):985-992. PubMed ID: 32503408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of transient receptor potential channel blockers in human gastric cancer cell viability.
    Kim BJ; Kim SY; Lee S; Jeon JH; Matsui H; Kwon YK; Kim SJ; So I
    Can J Physiol Pharmacol; 2012 Feb; 90(2):175-86. PubMed ID: 22308955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of kinase-coupled TRP channels in mineral homeostasis.
    Chubanov V; Mittermeier L; Gudermann T
    Pharmacol Ther; 2018 Apr; 184():159-176. PubMed ID: 29129644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [TRPM7 and tumor].
    Zhao M; Luo C; Wang Y; Wang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Mar; 41(3):333-6. PubMed ID: 27033800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7.
    Li M; Jiang J; Yue L
    J Gen Physiol; 2006 May; 127(5):525-37. PubMed ID: 16636202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function and regulation of the channel-kinase TRPM7 in health and disease.
    Visser D; Middelbeek J; van Leeuwen FN; Jalink K
    Eur J Cell Biol; 2014 Oct; 93(10-12):455-65. PubMed ID: 25073440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.